Ed is an experienced investor relations and corporate communications consultant with over 15 years building and leading programs, across material science, medical device, and pharmaceutical small to mid-cap companies, including pre-IPO and well established publicly traded companies.

As an IR practitioner, Ed comes to LaVoieHealthScience from Acceleron Pharma, where he was Director, Investor Relations. Prior to that role, he was Head of IR and Communications at Akebia Therapeutics and Director, IR and BD at Global Medical. Ed has an MBA in Finance from University of Connecticut and a BS in Chemical Engineering from Northeastern University.